Literature DB >> 2123805

Intracellular immunization. Cloning and intracellular expression of a monoclonal antibody to the p21ras protein.

T M Werge1, S Biocca, A Cattaneo.   

Abstract

Following the demonstration that intracellular expression of antibodies ('intracellular immunization') may be utilized to engineer new traits in mammalian cells, we undertook experiments to perturb the function of p21ras proteins, by engineering the intracellular expression of the anti-p21ras antibody Y13-259. The variable regions of this antibody have been cloned and, after verifying their antigen binding activity, expressed in general purpose vectors for the intracellular expression of antibodies. The results confirmed that the cloned antibody has been efficiently expressed both in the secretory and the intracellular forms. Thus, intracellular immunization of mammalian cells against p21ras, or any other antigen for which a monoclonal antibody is available, can now be performed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2123805     DOI: 10.1016/0014-5793(90)81362-r

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Intracellular immunization: Expression of antibody domains in the cytoplasm and in the nucleus of mammalian cells.

Authors:  S Biocca; A Di Luzio; T Werge; A Cattaneo
Journal:  Cytotechnology       Date:  1991-02       Impact factor: 2.058

2.  'Phytoantibodies': a general vector for the expression of immunoglobulin domains in transgenic plants.

Authors:  E Benvenuto; R J Ordàs; R Tavazza; G Ancora; S Biocca; A Cattaneo; P Galeffi
Journal:  Plant Mol Biol       Date:  1991-10       Impact factor: 4.076

Review 3.  Expression of engineered antibodies in plant cells.

Authors:  U Conrad; U Fiedler
Journal:  Plant Mol Biol       Date:  1994-11       Impact factor: 4.076

4.  Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system.

Authors:  P Piccioli; F Ruberti; S Biocca; A Di Luzio; T M Werge; A Bradbury; A Cattaneo
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

5.  Inhibition of human immunodeficiency virus type 1 integrase by the Fab fragment of a specific monoclonal antibody suggests that different multimerization states are required for different enzymatic functions.

Authors:  E V Barsov; W E Huber; J Marcotrigiano; P K Clark; A D Clark; E Arnold; S H Hughes
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

6.  Ras Activity Oscillates in the Mouse Suprachiasmatic Nucleus and Modulates Circadian Clock Dynamics.

Authors:  Tsvetan Serchov; Antje Jilg; Christian T Wolf; Ina Radtke; Jörg H Stehle; Rolf Heumann
Journal:  Mol Neurobiol       Date:  2015-03-12       Impact factor: 5.590

7.  Design, intracellular expression, and activity of a human anti-human immunodeficiency virus type 1 gp120 single-chain antibody.

Authors:  W A Marasco; W A Haseltine; S Y Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-15       Impact factor: 11.205

8.  Elimination of endogenous aberrant kappa chain transcripts from sp2/0-derived hybridoma cells by specific ribozyme cleavage: utility in genetic therapy of HIV-1 infections.

Authors:  L Duan; R J Pomerantz
Journal:  Nucleic Acids Res       Date:  1994-12-11       Impact factor: 16.971

9.  Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras.

Authors:  B van Etten; T L M ten Hagen; M R de Vries; G Ambagtsheer; T Huet; A M M Eggermont
Journal:  Br J Cancer       Date:  2002-02-01       Impact factor: 7.640

10.  A novel anti-p21Ras scFv antibody reacting specifically with human tumour cell lines and primary tumour tissues.

Authors:  Ju-Lun Yang; Du-Xian Liu; Shi-Jian Zhen; Yun-Gang Zhou; Dai-Jun Zhang; Li-Ying Yang; Hao-Bing Chen; Qiang Feng
Journal:  BMC Cancer       Date:  2016-02-20       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.